STONKWHISPER
← Back to Intel
Insider ActivityAVTX

Doyle Mittie, Chief Medical Officer at Avalo Therapeutics, Inc., sold $230K of AVTX

Updated Jun 18, 2026
Doyle Mittie Chief Medical Officer
Avalo Therapeutics, Inc. · $AVTX
$230K Total Value
10,058 Shares Traded
$22.88 Price / Share
3,622 Shares Owned After
2026-05-07 Filing Date

Transaction Details

InsiderDoyle Mittie
TitleChief Medical Officer
CompanyAvalo Therapeutics, Inc.
TickerAVTX
Transaction TypeSale
Transaction Date2026-05-06
Shares Traded10,058
Price Per Share$22.88
Total Value$230K
Filed Date2026-05-07
Accession Number0001918845-26-000010

Ownership Context

Shares Owned After Transaction3,622
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001918845-26-000010

Other Insider Trades — AVTX

Other Trades by Doyle Mittie

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AVTX — Avalo Therapeutics, Inc. →

Track AVTX insider activity in real time on The Wire →

Get alerts when Doyle Mittie files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:15 UTC

Want real-time data? Access The Wire for live sentiment tracking.